Among the 1,211 patients, 190 (15.7%) had oligodendroglioma, 204 (16.8%) had IDH-mutant astrocytoma, and 817 (67.5%) had IDH-wildtype glioblastoma. The gene discussed is IDH1; the disease is astrocytoma (excluding glioblastoma).